STEPHANIE EDWARDS: Open Payments
NPI 1588171128 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 6 payments from 4 companies in 2025. Trend: 2023 $151 · 2024 $57 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, Auvelity, REXULTI, CAPLYTA.
Industry payments across MS — which companies pay providers there.
